✦ LIBER ✦
P140 Prognostic impact of 1q21 amplification in patients with multiple myeloma treated by velcade, thalidomide and any conventional chemotherapy
✍ Scribed by P. Nemec; P. Kuglik; V. Vranova; R. Zaoralova; H. Greslikova; A. Oltova; H. Filkova; P. Vidlakova; J. Smejkalova; R. Hajek
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 47 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0268-960X
No coin nor oath required. For personal study only.
✦ Synopsis
Conclusions: Among their pts with GI nHl the slow increase of incidence from all lymphoma cases, the slight decrease of MALT lymphomas, the elevation of cases of intestinal and of gastric lymphomas with high grade B-cell origin and at all, in this latter group the beneficial effect of rituximab+CHOP treatment were observed.
P140 Prognostic impact of 1q21 amplification in patients with multiple myeloma treated by velcade, thalidomide and any conventional chemotherapy